Schönekess B O, Allard M F, Henning S L, Wambolt R B, Lopaschuk G D
Cardiovascular Research Group, University of Alberta, Edmonton, Canada.
Circ Res. 1997 Oct;81(4):540-9. doi: 10.1161/01.res.81.4.540.
Although hypertrophied hearts have increased rates of glycolysis under aerobic conditions, it is controversial as to whether glucose metabolism during ischemia is altered in the hypertrophied heart. Because endogenous glycogen stores are a key source of glucose during ischemia, we developed a protocol to label the glycogen pool in hearts with either [3H]glucose or [14C]glucose, allowing for direct measurement of both glycogen and exogenous glucose metabolism during ischemia. Cardiac hypertrophy was produced in rats by banding the abdominal aorta for an 8-week period. Isolated hearts from aortic-banded and sham-operated rats were initially perfused under substrate-free conditions to decrease glycogen content to 40% of the initial pool size. Resynthesis and radiolabeling of the glycogen pool with [3H]glucose or [14C]glucose were accomplished in working hearts by perfusion for a 60-minute period with 11 mmol/L [3H]glucose or [14C]glucose, 0.5 mmol/L lactate, 1.2 mmol/L palmitate, and 100 mumol/mL insulin. Although glycolytic rates during the aerobic perfusion were significantly greater in hypertrophied hearts compared with control hearts, glycolytic rates from exogenous glucose were not different during low-flow ischemia. The contribution of glucose from glycogen was also not different in hypertrophied hearts compared with control hearts during ischemia (1314 +/- 665 versus 776 +/- 310 nmol.min-1.g dry wt-1, respectively). Glucose oxidation rates decreased during ischemia but were not different between the two groups. However, in both hypertrophied and control hearts, the ratio of glucose oxidation to glycolysis was greater for glucose originating from glycogen than from exogenous glucose. Our data demonstrate that glycogen is a significant source of glucose during low-flow ischemia, but the data do not differ between hypertrophied and control hearts.
尽管肥大心脏在有氧条件下糖酵解速率增加,但关于肥大心脏在缺血期间葡萄糖代谢是否改变仍存在争议。由于内源性糖原储备是缺血期间葡萄糖的关键来源,我们开发了一种方案,用[3H]葡萄糖或[14C]葡萄糖标记心脏中的糖原池,以便在缺血期间直接测量糖原和外源性葡萄糖代谢。通过结扎腹主动脉8周在大鼠中产生心脏肥大。将来自主动脉结扎和假手术大鼠的离体心脏最初在无底物条件下灌注,以使糖原含量降低至初始池大小的40%。通过用11 mmol/L [3H]葡萄糖或[14C]葡萄糖、0.5 mmol/L乳酸、1.2 mmol/L棕榈酸酯和100 μmol/mL胰岛素灌注60分钟,在工作心脏中完成糖原池的再合成和用[3H]葡萄糖或[14C]葡萄糖进行放射性标记。尽管与对照心脏相比,肥大心脏在有氧灌注期间的糖酵解速率显著更高,但在低流量缺血期间,来自外源性葡萄糖的糖酵解速率并无差异。在缺血期间,肥大心脏与对照心脏相比,糖原中葡萄糖的贡献也没有差异(分别为1314±665与776±310 nmol·min-1·g干重-1)。缺血期间葡萄糖氧化速率降低,但两组之间并无差异。然而,在肥大心脏和对照心脏中,源自糖原的葡萄糖的葡萄糖氧化与糖酵解的比率均高于源自外源性葡萄糖的葡萄糖。我们的数据表明,在低流量缺血期间,糖原是葡萄糖的重要来源,但肥大心脏和对照心脏的数据并无差异。